NPHC — Nutra Pharma Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.76m
- $8.85m
- $0.10m
Annual balance sheet for Nutra Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0 | 0 | 0 | 0 | 0.091 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.285 | 0.017 | 0.032 | 0.04 | 0.325 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.358 | 0.115 | 0.058 | 0.055 | 0.534 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.016 | 0.011 | 0.214 | 0.159 | 0.139 |
Other Long Term Assets | |||||
Total Assets | 0.39 | 0.141 | 0.34 | 0.302 | 0.78 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 5.8 | 6.03 | 11 | 11.5 | 21.1 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 5.8 | 6.08 | 12 | 11.8 | 21.7 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -5.41 | -5.94 | -11.7 | -11.5 | -20.9 |
Total Liabilities & Shareholders' Equity | 0.39 | 0.141 | 0.34 | 0.302 | 0.78 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |